Medalia

Medalia is a biotechnology company focused on the discovery and development of novel therapeutics by leveraging advanced structural biology techniques, specifically cryo-electron tomography (cryo-ET). The company specializes in visualizing cellular structures and protein complexes in their native environment at near-atomic resolution to identify unique binding sites for drug discovery. Their primary research focus involves targeting the cytoskeleton, including actin and microtubules, to develop next-generation treatments for oncology and other diseases. By integrating high-resolution imaging with computational modeling, Medalia aims to accelerate the design of highly specific small molecule inhibitors.